78 related articles for article (PubMed ID: 10375768)
1. Long-term toxicity of modified recombinant human tumor necrosis factor in Macaca mulatta.
Gu CH; Yuan BJ; Lu GC; Dai ZR; Liu JP; Zhang SY; Zhang P; Jiang CL
Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):85-8. PubMed ID: 10375768
[TBL] [Abstract][Full Text] [Related]
2. A novel human tumor necrosis factor alpha mutant showed potent antitumor activity and reduced toxicity in vivo.
Lu F; Chen ZM; Liu QH; Chen CQ
Acta Pharmacol Sin; 2001 Jul; 22(7):619-23. PubMed ID: 11749826
[TBL] [Abstract][Full Text] [Related]
3. Toxicity of intravesical recombinant human tumor necrosis factor in cynomolgus monkeys.
Bahnson RR; Ballou BT; Ernstoff MS; Cramer DV; Schwentker FN; Reiland JM; Hakala TR
J Biol Response Mod; 1990 Aug; 9(4):445-7. PubMed ID: 2395009
[TBL] [Abstract][Full Text] [Related]
4. Tissue distribution of recombinant human tumor necrosis factor alpha derivative in mice.
Chai BX; Tang ZM; Liu XW; Tu M
Zhongguo Yao Li Xue Bao; 1999 Apr; 20(4):371-4. PubMed ID: 10452128
[TBL] [Abstract][Full Text] [Related]
5. [Inducement effect of recombinant human TNF-alpha on apoptosis of breast cancer cell line ZR75-1 and Its mechanism].
Li YC; Kong LH; Li KS
Ai Zheng; 2006 May; 25(5):560-5. PubMed ID: 16687074
[TBL] [Abstract][Full Text] [Related]
6. Manipulation of oxygen radical-scavenging capacity in mice alters host sensitivity to tumor necrosis factor toxicity but does not interfere with its antitumor efficacy.
Hauser GJ; McIntosh JK; Travis WD; Rosenberg SA
Cancer Res; 1990 Jun; 50(12):3503-8. PubMed ID: 2340500
[TBL] [Abstract][Full Text] [Related]
7. Preventive effects of several chemicals against lethality of recombinant human tumor necrosis factor.
Satomi N; Sakurai A; Haranaka R; Haranaka K
J Biol Response Mod; 1988 Feb; 7(1):54-64. PubMed ID: 3373234
[TBL] [Abstract][Full Text] [Related]
8. New TNF-alpha analogues: a powerful but less toxic biological tool against tumours.
Novaković S; Menart V; Gaberc-Porekar V; Stalc A; Sersa G; Cemazar M; Jezersek B
Cytokine; 1997 Aug; 9(8):597-604. PubMed ID: 9245488
[TBL] [Abstract][Full Text] [Related]
9. Comparative studies on the ultrastructure of the rat lungs after intratumor treatment of Morris hepatoma with rhTNF-alpha and its muteins.
Terlikowski S; Sulkowski S; Sulkowska M; Nowak HF
J Submicrosc Cytol Pathol; 1999 Apr; 31(2):265-72. PubMed ID: 10457612
[TBL] [Abstract][Full Text] [Related]
10. [Effects of anti-rhTNF alpha monoclonal antibody on oxygen extraction in endotoxemic rabbits].
Wu XY; Han LP; Zhu MG; Zhang ZH; Zhang LF
Sheng Li Xue Bao; 1997 Aug; 49(4):445-51. PubMed ID: 9812878
[TBL] [Abstract][Full Text] [Related]
11. A mutated human tumor necrosis factor-alpha improves the therapeutic index in vitro and in vivo.
Yan Z; Zhao N; Wang Z; Li B; Bao C; Shi J; Han W; Zhang Y
Cytotherapy; 2006; 8(4):415-23. PubMed ID: 16923618
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor alpha (rhTNF) fails to stimulate angiogenesis in the rabbit cornea.
Phillips GD; Stone AM; Schultz JC; Jones BD; Lisowski MJ; Goodkin ML; Knighton DR
Anat Rec; 1996 May; 245(1):53-6. PubMed ID: 8731040
[TBL] [Abstract][Full Text] [Related]
13. Studies of the mechanisms of toxicity of the administration of recombinant tumor necrosis factor alpha in normal and tumor-bearing mice.
Krosnick JA; McIntosh JK; Mulé JJ; Rosenberg SA
Cancer Immunol Immunother; 1989; 30(3):133-8. PubMed ID: 2598182
[TBL] [Abstract][Full Text] [Related]
14. Downstream technique study of human tumor necrosis factor alpha and its mutant.
Xu H; Gao C; Liu H; Deng F; Pan H; Chen C
Chin J Biotechnol; 1998; 14(2):109-15. PubMed ID: 10196635
[TBL] [Abstract][Full Text] [Related]
15. Low susceptibility of NC/Nga mice to tumor necrosis factor-alpha-mediated lethality and hepatocellular damage with D-galactosamine sensitization.
Koide N; Morikawa A; Naiki Y; Tumurkhuu G; Yoshida T; Ikeda H; Yokochi T
Clin Immunol; 2009 Feb; 130(2):225-32. PubMed ID: 18945641
[TBL] [Abstract][Full Text] [Related]
16. NTP technical report on the toxicity studies of Cupric Sulfate (CAS No. 7758-99-8) Administered in Drinking Water and Feed to F344/N Rats and B6C3F1 Mice.
Hebert C
Toxic Rep Ser; 1993 Jul; 29():1-D3. PubMed ID: 12209195
[TBL] [Abstract][Full Text] [Related]
17. [Experimental study of the effect of rhTNF-alpha on human sperm mitochondrial function and motility in vitro].
Bian J; Guo X; Xiong C; Li J; Tian Y; Ma H; Zhang Y; Nie Y; Yu L; Xiao L
Zhonghua Nan Ke Xue; 2004 Jun; 10(6):415-9. PubMed ID: 15267202
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of a tumor necrosis factor-alpha phosphorothioate 2'-O-(2-methoxyethyl) modified antisense oligonucleotide: comparison across species.
Geary RS; Yu RZ; Watanabe T; Henry SP; Hardee GE; Chappell A; Matson J; Sasmor H; Cummins L; Levin AA
Drug Metab Dispos; 2003 Nov; 31(11):1419-28. PubMed ID: 14570775
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of PEGylated adducts of recombinant human tumor necrosis factor-alpha from Escherichia coli.
Li W; Wang Y; Zhu X; Li M; Su Z
J Biotechnol; 2002 Jan; 92(3):251-8. PubMed ID: 11689249
[TBL] [Abstract][Full Text] [Related]
20. [Experimental study of anti-tumour effect of rhTNF alpha on the laryngeal squamous cell carcinoma].
Ye J; Xu X; Shi L
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1997 Aug; 32(4):230-2. PubMed ID: 10743172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
